| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Platinum Discovery Multiomics research for precision medicines Platinum Discovery offers a cutting-edge Tumour-to-Target Platform, specialising in cancer vaccine development through the identification of tumour-specific neoantigens. We provide a comprehensive, end-to-end drug discovery pipeline, supporting clinical trial research and translational science for patient samples. Our multidisciplinary team brings together expertise in biology, clinical sciences, multi-omics technologies, bioinformatics, and computational sciences, enabling a deep understanding of the biological processes critical to drug development. We excel at integrating diverse scientific domains to deliver holistic, innovative solutions. With extensive experience in designing and managing complex research programmes, we assemble tailored teams of experts, drawing on our … Type: | 0 | 0 | 0 | 3 |
 | Koniku Bio is TechTM At Koniku Inc., we take the view that a biological neuron is a *material*. An intelligent material or component to be utilized in real life products or devices. Clearly, this proposition opens up a unique set of technology challenges, solvable. It simultaneously offers up an unimaginably vast trove of opportunities. Opportunities ranging from pure-play neurotech, *living devices* to advanced brain-machine interfaces. Koniku is the worlds first corporation of its kind. We are the leading brand in neurotechnology devices. Our goal is to harness the "raw" biological basis of intelligence. Our maxim is: “Bio is TechTM”. We are … Type: | 9 | 3 | 6 | 4 |
 | Vortex Biosciences Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have entered the patient bloodstream. These CTCs are known to be the key cause of secondary tumors in patients. As a result, the number and type of CTCs in a patient blood is highly indicative of the status of cancer in that patient. CTCs provide insight into the source of the primary tumor, grade, invasiveness, response to therapy and recurrence. As an indication, approximately 1.5 million new cancer patients are diagnosed per year in the United States, and around 20 million existing patients are undergoing … Type: | 1 | 1 | 1 | 6 |
 | Multus Feeding food. 🔵 What do we do? Multus is reinventing growth media for cell culture in cultivated meat and life science. From growth factors to serum-free supplements, we partner with companies looking for media breakthroughs to help accelerate their progress and de-risk their supply chain. 🔵 How do we do it better? We use a groundbreaking combination of data science, high-throughput automation and ISO-certified manufacturing to develop ingredients and formulations that reduce costs, eliminate animal-sourced components and enable scale-up. 🔵 Why do we do it? Our Mission is to make cultivated meat the sustainable and affordable choice, for everyone. To … Type: | 16 | 3 | 11 | 28 |
 | LimFlow Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 1 | 0 | 29 |
 | Vetbiobank Leading Animal Cell Therapy - Improving Animal Healthcare. Vetbiobank is a biotech company specialized in veterinary regenerative medicine. For our customers and their animal companions (dogs, cats, horses), we are leveraging the unique biological potential of neonatal stem cells. Those stem cells deliver locally an appropriate set of bioactive messages to organise and promote the harmonious healing of injuries or dampen inflammatory chronic diseases. Funded in 2011, Vetbiobank has built its expertise on the experience of its founder, former expert in human cell therapy development, and cord blood derived stem cells. The mission of Vetbiobank is to provide veterinarians with … Type: | 5 | 2 | 3 | 10 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 4 | 1 | 1 | 114 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … Type: | 3 | 1 | 3 | 6 |
 | MagIA diagnostics Your immunoassay: Faster, Simpler, Accessible MagIA is developing a multi-analyis "Point-of-Care" that can be used outside of any clinical environment. With a first focus on infectious diseases MagIA is providing a syndromic testing approach at the Point of Care outside of traditional clinical environment. With the motto “a better screening for a better care", MagIA focuses first on the rapid detection of infectious diseases, starting with an HIV-Viral Hepatitis combo, to link to care Key « high-risk » populations. MagIA's innovation is a one-step no-wash immunoassay method which brings unique characteristics: (1) laboratory quality on a portable device, usable indoor, … | 16 | 6 | 4 | 15 |
 |  Osmoz Lab [Automatic translation follows] The first range of food supplements compatible with chemotherapy treatments. Osmoz Lab has created the very first range of food supplements compatible with chemotherapy treatments. Developed by a Doctor of Pharmacy, the Osmoz range reduces the side effects of chemotherapy naturally and without interaction. 🌱 100% natural origin 🔬 Formulation based on clinical study results ⚗️ Based on dry plant extracts for optimal effectiveness 💊 Capsule of plant origin 🇫🇷 Made in France Type: | 3 | 3 | 0 | 1 |
 | SmartCatch For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was … Type: | 16 | 5 | 13 | 20 |
 | CrocosGoDigital [Automatic translation follows] AI for cognitive stimulations for kids by coding robots/drones/..., and brain dysfunctions detection. CrocosGoDigital is a start-up specialized in Neuro-Education for children 6-12 years old and seniors - use of neuroscience and AI for a new generation of training in Programming robots, drones, AI engines, ... The objective is to boost/stimulate the cognitive functions of children and seniors, whatever their level, precocious or with learning difficulties, to make them progress at their own pace through motivation. This is why our training is 'adaptive', and designed to stimulate cognitive functions. Ultimately, with our partners in Neuroscience and our … Type: | 22 | 9 | 3 | 10 |
 | Antofénol [Automatic translation follows] Our vision: Obtain the best of the plant, without using conventional chemical solvents. Our know-how: - Simultaneously exploit 4 proven eco-extraction technologies. - Provide solutions for the development of your ingredients in order to enrich your range of active biomolecules (polyphenols, flavonoids, alkaloids) Our objective: Offer eco-responsible solutions to enable you to meet the ecological and economic challenges of the future. vacuum distillation, plant eco-extraction, R&D, objective ingredients, microwaves, ultrasound, atomization, freeze-drying, grinding, natural extracts, active ingredient, 100% natural active ingredients, eco-responsible, polyphenols, essential oils, cosmetics, perfumery, nutraceuticals, and agri-food Type: | 13 | 7 | 7 | 19 |
 |  Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 46 | 12 | 23 | 58 |
 |  LYSOGENE Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early … Type: | 8 | 6 | 0 | 10 |
 | Fiberly Cotton-inspired proprietary textile fibers. At Fiberly we turn cellulosic textile waste into high-quality fibers featuring a molecular structure similar to cotton. | 0 | 0 | 0 | 5 |
 | Eurosafe CRO [Automatic translation follows] Eurosafe is a Good Laboratory Practice (GLP) certified contract research company (CRO), specializing in human and veterinary pharmaceutical products, cosmetic products (ingredients and finished products), food supplements and medical devices. Depending on your products, a single contact, surrounded by scientists and regulatory experts, will assist you in defining and carrying out the regulatory procedures, carrying out the ADME (Absorption, Distribution, Metabolism and Elimination), safety, tolerance or efficacy tests required for marketing your products. Eurosafe is a unique CRO with multiple skills, organized around 3 complementary areas: - In vitro tests - Tests on volunteers - Toxicological and … Type: | 5 | 0 | 5 | 18 |
 | COULEURS DE PLANTES Fabricant français extraits colorants et pigments végétaux teinture et impression textile, savonnerie, loisirs créatifs COULEURS DE PLANTES is a chemicals company based out of ZI DE L ARSENAL 18 RUE DE L ARSENAL, ROCHEFORT, France. | 0 | 0 | 0 | 4 |
 | COVERTIS COVERTIS is a biotechnology company based out of Ester Technopole, Limoges, France. | 0 | 0 | 0 | 2 |
 | IRCM - Institut de Recherche en Cancérologie de Montpellier "Des concepts aux biomarqueurs et innovations en médecine de précision" The Cancer Research Institute of Montpellier U1194 jointly operated by Inserm, University of Montpellier and Institut du Cancer de Montpellier (CLCC) 220 scientists and support personnel 17 research teams sharing 5000 m2 of lab space Excellent core facilities, many being part of the shared facilities network Montpellier BioCampus Biotech spin-offs Ground breaking research in basic and translational oncology developed in close collaboration with clinical departments and clinical research at ICM One central theme and two unifying programs : Molecular Targets and Cancer Therapy 1. Plasticity of solid tumors : from … Type: | 4 | 1 | 3 | 131 |
 | SAS IMPROVE IMPROVE an alternative protein CDMO Located in Dury near Amiens, The SAS IMPROVE is The Protein Innovation Center fully dedicated to alternative source of proteins. We produce and study nutritious and functionnal protein ingredients for food, feed and cosmetic applications. IMPROVE provide a high level of expertise from fundamental research to market knowledge. Industrial experience, scientific expertise, chemists and biochemists, process ingeneers...With a 800m2 pilot plant and 170m2 of laboratories IMPROVE offers a unique combination of skills and equipment to boost innovation and value generation for: Reducing time to market for new proteins products Enabling breakthrough innovations that meet market’s … Type: | 12 | 4 | 0 | 29 |
 | Verso Energy [Automatic translation follows] Building a competitive, decarbonized energy mix with a high proportion of renewable energies Verso Energy specializes in the development, engineering, financing, construction and operation of controllable renewable energy production facilities, electricity storage facilities for the provision of services to electricity grids, and decarbonized hydrogen and synthetic molecule production facilities (e-methanol, e-SAF). Hydrogen, Renewables, e-molecules, Power-to-X, Flexibility, Battery storage, Power, Decarbonation, CO2 Capture, and Project development Type: | 20 | 6 | 17 | 62 |
 | BGene Genetics Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, and Bioprocess Type: | 11 | 6 | 5 | 16 |
 | DiogenX Targeting Beta Cell recovery in Diabetes DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world. Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits. DiogenX is headquartered in Marseille, with labs in Nice (France). Biotechnology and Diabetes Type: | 4 | 2 | 3 | 19 |
 | PepKon PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families Type: | 9 | 6 | 6 | 7 |
 | Valbiotis Valbiotis is a commercially oriented Research & Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach by developing a new class of health nutrition products designed to reduce the risk of major metabolic and cardiovascular diseases, relying on a multi-target strategy enabled by the use of plant-based terrestrial and marine resources. Created at the beginning of 2014 in La Rochelle, the Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63) – and a subsidiary in Quebec City … Type: | 29 | 17 | 17 | 49 |
 | Nektium Pharma Nektium is an innovative ingredients company that discovers, develops & commercializes science-based botanical extracts. Nektium is a Spain-based nutraceutical company that combines ethnobotanical knowledge, science, and market insights to create innovative plant-based solutions, promoting sustainable & healthy living worldwide. Our product portfolio covers a range of health benefits, with a particular focus on cognition, sports & active nutrition as well as weight management. With a deep understanding of botanicals and state-of-the-art and eco-friendly technology, Nektium focuses with an experience of over 25 years on quality and full transparency along the entire value chain to deliver proven solutions to the market … Type: | 1 | 0 | 0 | 30 |
 | KGK Science Inc. Leading contract research organization in the nutraceutical & cannabinoid industries. Scientific & regulatory services. Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical, cannabis and hemp industries, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies. From clinical study design to … | 4 | 0 | 3 | 52 |
 | Biofrontera Group We aim to protect and heal your skin with our innovative photodynamic therapy medication. Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company … Type: | 0 | 0 | 0 | 87 |
 | Biotech Dental Since its creation in 1987, Biotech Dental has been committed to building a trusting and lasting relationship with dental surgeons and dental technicians. Together, we design and develop a range of product that is continually more adapted to the challenges of the future. We have positioned ourselves at the crossroads of our customers’ expectations, innovation and technology. Giving dentists the ability to suggest the best products at the best price to their patients is Biotech Dental’s first objective. With more than 2 million dental implants sold, we have improved the lives of thousands of patients worldwide thanks to all the … Type: | 11 | 6 | 4 | 320 |
 | ADVANZ PHARMA Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more … Type: | 1 | 0 | 1 | 645 |
 | Codexis, Inc. We deliver exquisite enzymes for the betterment of human health. Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic … Type: | 10 | 0 | 9 | 249 |
 | Flindr Therapeutics Flindr develops first-in-class precision oncology therapies identified through the Immunogram Drug Discovery Engine Flindr Therapeutics, based in Oss in the Netherlands, is a private pre-clinical biotech company developing next-generation precision oncology treatments. The Company, previously called Immagene, was spun out of the Netherlands Cancer Institute (NKI) and Oncode Institute in 2020, by founders Prof Daniel Peeper, Prof Christian Blank and Dr Maarten Ligtenberg. Flindr is actively building a pipeline of highly promising, first-in-class precision oncology therapies identified through the ImmunoGram Drug Discovery Engine. It is backed by V-Bio Ventures, Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future … Type: | 0 | 0 | 0 | 6 |
 | Sareum Ltd Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases and has entered Phase 1a/b clinical development with an initial focus on psoriasis. Sareum has an economic interest in SRA737, a clinical-stage Chk1 inhibitor which it originally developed in collaboration with several Cancer Research UK-related organisations. SRA737 has shown … Type: | 0 | 0 | 0 | 6 |
 | DelSiTech Ltd The natural solution for drug delivery DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend … Type: | 0 | 0 | 0 | 52 |
 | DEINOVE Investing dark biodiversity DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the microbial dark matter. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance. The new therapies discovered and developed by DEINOVE (antibiotics, antifungals, antivirals and antiparasitics) target superbugs (microbes that resist to one or several antimicrobials) that cause life-threatening infections which are now spreading at high speed. This breakthrough approach gave birth to one of the World first specialized micro-biotechnology platforms and a unique collection … | 8 | 5 | 2 | 17 |
 | Medicrea Pioneering the digital transformation of spinal surgery through A.I., predictive modeling and patient-specific implants. Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room. Operating in a $10 billion marketplace, MEDICREA® is a Small and Medium sized Enterprise (SME) with 210 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing … Type: | 1 | 1 | 0 | 70 |
 | Keyrus Life Science The C2RO that helps connect Industry Expertise, Life Data Sciences and Digital Enablement. Keyrus Life Science is a Connected Contract Research Organization (C2RO), active for almost 25 years internationally, and part of the Keyrus group, an expert in data and digital solutions. Combining in-depth scientific and industry expertise, a deep understanding of life data sciences, and the integration of cutting-edge digital technologies, Keyrus Life Science optimizes the conduct of clinical trials and RWE projects, bringing greater agility and reliability, increasing their resilience and performance, and accelerating their execution. Keyrus Life Science supports life science industrials, such as the Pharmaceutical, Biotech … Type: | 2 | 2 | 1 | 211 |
 | Biospace Lab Imaging for discoveries Molecular Imaging in Real Time Biospace Lab - originally Biospace Mesures - was founded in 1989 by Nobel Prize winner Georges Charpak to provide fellow researchers in biology with innovative imaging tools based on his discoveries in high-energy physics and particle detection. Since then, Biospace Lab has pursued and created strong links with medical, pharmaceutical and scientific communities to bring relevant and creative solutions to biomedical imaging needs. Today, Biospace Lab range of instruments, developed with patented technologies, is dedicated to high-performance imaging for pre-clinical research in drug discovery and biology. Biospace Lab instruments and software are … Type: | 3 | 0 | 3 | 14 |
 | Plastomics, Inc. Plastomics is developing next generation trait delivery technology that leverages the power of chloroplasts. Plastomics' novel trait delivery technology harnesses the power of the plant cell to create crops than can better withstand the pressure of insects, diseases and weeds and that are more efficient and deliver higher yields. Plastomics technology will give seed companies the benefits of simplified product development, more effective products and new market opportunities. plant transformation, chloroplast transformation, agricultural biotechnology, soybean transformation, and corn transformation Type: | 1 | 1 | 0 | 27 |
 | Immunophotonics, Inc. Interventional Immuno-Oncology Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their … Type: | 1 | 0 | 1 | 18 |
 | NexaBiome Targeted phage technology, safeguarding human and animal health by harnessing sustainable, antibacterial technology NexaBiome's patented technology enables bacteriophages to be covalently attached to a wide variety of substrates; this gives them enhanced stability for use in a variety of applications which address two of the world's major challenges, antibiotic resistance and food supply and sustainability. By attaching specific bacteriophages to fish and animal feeds, we can reduce, augment or even substitute for antibiotics in the food chain. This lets us target both human and animal pathogens, such as E. coli, Listeria, Campylobacter, Salmonella, Streptococcus, Pseudomonas, Flavobacteria and others. As our … Type: | 1 | 1 | 0 | 13 |
 | Scandinavian ChemoTech AB (publ) ChemoTech is a R&D based company in the field of oncology. The Company is presently marketing and selling it's IQwaveTM TSE (Tumour Specific ElectroporationTM) system which is an innovation within the field of electroporation. ChemoTech's products are presently available in Europe, India and South East Asia. The treatment is developed to treat patients with large and 'hard to treat' superficial tumours. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm. The Company is headquartered in Lund, Sweden. We have also a device for our Animal Care division called vetIQureTM, this device is being marketed and handled by … | 2 | 0 | 2 | 10 |
 | Exploragen Exploragen builds innovative tools and products that connect individuals’ unique DNA to engaging, fun experiences and information. Apps like SlumberType are the first step in this exploration of Bringing DNA to Life. Consumer Genomics, Technology, DNA, Software Applications, Genetics, DTC Consumer Genomics, Genetic App Store , Lifestyle, and Wellness Type: | 0 | 0 | 0 | 0 |
 | ApisProtect ApisProtect provides real-time hive monitoring powered by intelligent #sensor #technology. Founded by preeminent researchers in the use of sensors in beehives, ApisProtect provides real-time bee monitoring powered by intelligent sensor technology. ApisProtect gives beekeepers actionable insights and alerts to help prevent losses and increase colony productivity. Dr Fiona Edwards Murphy, CEO and Co-Founder of ApisProtect is among the most widely published authors on Internet of Things and honey bees. Dr. Edwards Murphy's work on the topic of hive monitoring has received many national and international awards from the Irish Research Council, The IEEE, IBM, The Irish Laboratory Awards, Google, and … Type: | 18 | 4 | 14 | 3 |
 | AbCellera Antibody discovery engine AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, and Bispecifics Type: | 11 | 1 | 4 | 585 |
 | Assay Genie Creating World-Class Assays, Immunoassays, Antibodies & Proteins Assay Genie is a global life reagents company with over 120,000 products including immunoassays, antibodies, proteins & activity assays for research and development scientists. Founded in 2017, Assay Genie has offices in Dublin, Ireland & London, UK. With distributors in over 70 countries, Assay Genie works with scientists all around the World and counts Pfizer, J&J, Harvard University and many more of the World’s leading companies & universities among its customers. Company Achievements & Core Technologies Since its inception in 2017, Assay Genie has gone form strength-to-strength. The company began by building a … Type: | 0 | 0 | 0 | 18 |
 | 3BarBio Design · Develop · Deliver 3BarBio offers increased profitability to discovery companies, bulk suppliers, and distributors by addressing the major hurdle to further adoption of biologics by designing innovative packaging to deliver viable microbes to the ag market. With its proprietary LiveMicrobe® Design. Develop. Deliver. process, 3Bar delivers on demand for partners around the world. Manufacturing, Innovative Packaging, Engineering, Supply Chain, and Agricultural Biologicals Type: | 0 | 0 | 0 | 27 |
 | Barinthus Biotherapeutics Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of … Type: | 12 | 4 | 6 | 119 |
 | BioLogos BioLogos explores God’s Word and God’s World to inspire authentic faith for today. BioLogos explores God’s Word and God’s World to inspire authentic faith for today. evolution, creationism, intelligent design, biblical scholarship, genetics, cell biology, christianity, jesus, theology, creation care, bioethics, christian ethics, and human identity Type: | 0 | 0 | 0 | 33 |
 | CytoReason The First Cell-Centered Computational Model of Human Disease CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain … Type: | 7 | 1 | 4 | 135 |
 | Oculis Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal is to improve the … Type: | 3 | 1 | 2 | 51 |
 | Presentient Technologies Ltd Predicting clinical trial outcomes in realtime Since the 1950s, the cost to develop a drug has been doubling every 9 years meaning fewer affordable drugs. Presentient aims to rapidly reverse this trend. At Presentient, we are the first to autonomously analyse blinded data coming out of clinical trials in realtime. This will shorten clinical trials from years to months and unleash a wave of innovative new medicines for patients that are actually affordable. Clinical trials and Data analytics Type: | 0 | 0 | 0 | 3 |
 | Cellbox Solutions LIVE CELL SHIPMENT Cellbox Solutions is a young technology company focusing on delivering innovative and new solutions for the correct handling of living cells and biologic structures. Our product Cellbox is a self-sustaining carbon dioxide incubator supporting the appropriate storage, reproduction, transportation and analysis of biologic materials. The incubator’s temperature and gas environment can be adjusted based on the biosphere necessary for the cultivating cells stored. Biotechnology, Cell Transportation, Temperature Regulation, BioTech, Logistics, CO2 Solutions, Cell Cultures, Biological Structures, Preclinical Services, Live cell transport, portable CO2 incubator, and portable incubator Type: | 3 | 0 | 3 | 22 |
 | PhiTech Bioinformatics More Omics into Clinics PhiTech Bioinformatics translates genome-wide molecular data (Genomics, Transcriptomics, Epigenomics, Microbiomics, etc.) into biotechnology solutions primarily for use in precision medicine. We are moving beyond genomics by applying cutting-edge algorithms to extract information critical for diagnostic decision making. We are currently focusing on development of RNA-based diagnostics. Follow us on Twitter @PhiTech_Bioinfo Bioinformatics, Genomics, Transcriptomics, Epigenomics, and Microbiomics Type: | 1 | 0 | 0 | 29 |
 | Virax Biolabs Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. medical device development, medical device distribution, Logistics, Procurement, Distribution, IOTH, Innovation, T-Cells, and immunology Type: | 0 | 0 | 0 | 25 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 5 | 2 | 2 | 22 |
 | Turing Biosystems Harnessing the power of computation to deliver the right drugs, for the right people, at the right time. Turing Biosystems tackles high failure rates and adverse immune responses to immunotherapy and cell & gene therapy. Our software platform is based on a new kind of interpretable AI that works through automated reasoning. Built on specialized chips, it can integrate any and all modes of clinical/biological data, analyse patient responses to therapies, and design better healthcare interventions. We're here to help both clinicians and biopharma get the right treatments to the right patients at the right time. Type: | 11 | 1 | 3 | 9 |
 | Fibenol Fiber Beyond Oil Fibenol is a company that produces wood-based raw materials and is dedicated to redefining the forest industry through sustainable production and new-age technology. Our mission is to add value to industries by transforming wood residues to replace fossil-based materials with wood-based materials. At our flagship plant, we use a unique fractionation technology that easily converts woody residues into a processable liquid in just 20 seconds. From that, we further extract biobased building blocks that can be turned into much-needed low-carbon products for customers looking to switch over from fossil-based materials to bio-based raw materials in various industry … Type: | 4 | 2 | 2 | 25 |
 | Synbio Technologies Changing the world, one sequence at a time. Synbio Technologies aims to become the most trusted provider of DNA solutions that empower scientific discoveries by providing highly-accurate and cost-effective synthetic biology services and products for researchers around the world. We have developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more. Our scientific capabilities cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology … Type: | 1 | 1 | 0 | 27 |
 | Brevel Sustainable protein for the future of our planet Providing sustainable protein for a better future on this planet. Brevel's unique microalgae based protein is flavor and color neutral, has a full amino-acid profile, is highly functional and is affordable for the food industry. Thanks to our breakthrough technology, we introduce a paradigm shift to the microalgae and the plant based protein industries. Microalgae, Mixotrophy, Photobioreactor, Cultivation technology, Alternative protein, Protein, Dairy Alternatives, Egg Alternatives, and Meat Alternatives Type: | 3 | 2 | 2 | 36 |
 | SpacePharma Bring your research idea and we will make it happen SpacePharma is a unique powerhouse offering an affordable and accessible microgravity research, together with true innovation to R&D pipelines. Our mission is to become a world leader in providing simplified and valuable, end-to-end microgravity services and solutions for research. Microgravity is a disruptive opportunity for several major sectors: pharmaceuticals, biotechnology, chemistry and materials science. It provides companies and researchers with the ability to accelerate discovery processes for new drugs and vaccines, develop new crystals and materials and accelerate the study of human genome and origin of diseases. The potential scientific, … Type: | 5 | 5 | 0 | 18 |
 | ARRAYS FOR CELL NANODEVICES, SL - A4CELL Lab-in-a-cell-devices Dynamic film about cell sensing SPAchip® technology is based on intracellular silicon microchips printed with multiple fluorescent probes to analyse and monitor cellular pathways at real time intracellular processes. The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analysers. Suspended planar arrays, single cell analysis, cell signaling, flow cytometry, vaccines, and immunothepary Type: | 1 | 0 | 1 | 17 |
 | Axol Bioscience Ltd. World leaders in iPSC technology supporting the next generation of advanced models for drug discovery We provide biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to support drug discovery in the neurodegenerative, neuroinflammatory, and cardiotoxicity areas. As leaders in human induced pluripotent stem cell (iPSC) products and services, we support the pursuit of more human-relevant in vitro models to develop better, safer therapies. We have over a decade of experience supplying top ten Biopharma institutions and drug discovery companies with robust, high-quality in vitro models and custom lab services. Our industry-leading iPSC capabilities support the pursuit … Type: | 1 | 1 | 0 | 49 |
 | Rigenerand srl Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl. Originating as a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology, the cell technology company aims to fill therapeutic gaps for the many still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer With its team of leading cell therapy experts, Evotec (Moderna) adds a high-quality cGMP manufacturing site to the EVOcells platform increasing capacity, critical expertise, and capabilities … Type: | 1 | 1 | 0 | 5 |
 | Ncardia Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster. Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process … Type: | 1 | 1 | 0 | 62 |
 | Syngulon Original genetic technologies using bacteriocins. Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. … Type: | 5 | 2 | 2 | 9 |
 | EverImmune Harnessing the microbiome for the development of diagnosis and therapeutic tools in cancer ! EverImmune is a biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology. It harnesses the gut microbiota for the development of a unique approach aiming to restore the response of Immune Checkpoint Inhibitors (ICIs) in cancer patients. The company is developing Oncobax AK, a Live Biotherapeutic Product (LBP) used as an oral adjuvant to anticancer immunotherapies, designed to safely boost the immune system and restore sensitivity to immunotherapies in primary resistance settings. The company also develops other bacteria in … Type: | 2 | 0 | 2 | 4 |
 | SynDev [Automatic translation follows] Expertise in the orchestration of Biosolutions. SynDev helps players in the agricultural world in the choice, use and optimization of Biosolutions through a specific and innovative Decision Support Tool SynApps. SynDev is particularly aimed at companies wishing to develop agricultural sectors with a CSR approach, specific specifications or a catalog of solutions. Our ambition is to support our customers in the reduction and replacement of conventional phytosanitary products. SYNDEV has more than 20 years of expertise in the implementation of Biosolutions in cultivation routes. We support you throughout your process through training on the choice and use … Type: | 14 | 2 | 11 | 4 |
 | Algobiotech [Automatic translation follows] Specializing in the valorization of microalgae, Algobiotech is involved in the selection of new strains and the extraction of molecules of interest up to their exploitation in cosmetic applications, food supplements and therapeutics. Algobiotech aims to develop and market innovative products derived from microalgae for the aforementioned applications. Through its membership in GENOPOLE, the leading French bio cluster in biotechnology, Algobiotech benefits from a very favorable environment to find the right scientific and institutional partners to develop its R&D program around the identification and validation of the biological activities of molecules derived from microalgae. By relying on … Type: | 0 | 0 | 0 | 2 |
 | Aglaé [Automatic translation follows] The pioneering company of luminescent plants! Event services, interior and landscape design. We design scenographic installations for companies thanks to the magic of glowing plants. plant design, event, plant research, biology, scenography, innovation, floral decoration, interior decoration, landscaping, smartcity, biotechnology, start-up, Paris, Ile-de-France, agency, conception, light, design, urban planning, luminescent plants, green, and communication Type: | 23 | 10 | 17 | 37 |
 | STANIPHARM Expert services in supercritical CO2 and nanomedicines for the life science industry StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO drug delivery, supercritical fluids, formulation, nanoparticles, GMP manufacturing, poorly soluble drugs, sterilization, impregnation, … Type: | 2 | 2 | 0 | 12 |
 | Leads To Development Your expert drug development partner, guiding your asset to and through the clinic If you’ve only got one shot at getting your drug to the clinic, we’ll help you make it the best one. At Leads to Development, we enable biotech companies to bring novel drugs to and through clinical trials as efficiently and smoothly as possible. With decades of experience and more than 160 projects under our belt throughout Europe and the US, our team provides comprehensive end-to-end support across all areas of new drug development. Our backgrounds are in biotech rather than big pharma, so we understand the … Type: | 5 | 0 | 1 | 19 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 17 | 4 | 9 | 10 |
 | Poly-Dtech Enhance your detection Founded in 2019, Poly-Dtech is a French company, based in Strasbourg, specializing in innovative solutions for biomarker detection through an advanced cutting-edge technology: Bright-DtechTM 🎯 OUR MISSION: We aim to enhance current screening, drug discovery, and early disease diagnosis by advancing biomarker detection in scientific research and medical diagnostics. Poly-Dtech develops and produces immunoassays and Lateral Flow tests based on high-performance fluorescent nanoparticles with unique features. 🧪 BRIGHT-DTECHTM TECHNOLOGY: Bright-DtechTM represents a cutting-edge lanthanide-based fluorescent nanoparticles, surpassing existing products by significantly improving biomarker detection across diverse sample types and concentration levels, including previously undetected biomarkers. ⁃ User-friendly … Type: | 18 | 7 | 16 | 4 |
 | CALYSENS [Automatic translation follows] CALYSENS, a start-up specializing in the development of cosmetic products derived from scientific research. CALYSENS is a Marseille start-up located within OBRATORI - L'OCCITANE Innovation Lab at the Cité de l'Innovation et du Savoir in Aix-Marseille. It is based on the scientific research produced by the company ProGeLife, its main shareholder, founded by Professors Nicolas Lévy and Pierre Cau (Aix-Marseille University). CALYSENS' ambition is to effectively combat aging, photoaging and inflammatory skin stress. The specificity of CALYSENS lies in the scientific evidence of biological and clinical efficacy that it intends to provide in the fight against aging … | 1 | 1 | 0 | 2 |
 | Cytune Pharma SAS A biotechnology company shaping the future of cancer #immunotherapies by translating compelling science into patient benefit. Member of @PPFGroup | 2 | 0 | 2 | 1 |
 | Medtrucks Bring health to the patient Medtrucks is an innovative start-up in the healthcare sector, addressing the issue of lack of medical care in remote areas. Mobile hospital are deployed close to patient's home thanks to web mapping app. Medtrucks eases the daily life of patients with nearby healthcare. Cartographie, soins mobiles, santé, and biotechnologie Type: | 23 | 1 | 10 | 5 |
 | AUM Biosync [Automatic translation follows] We watch over those who watch over you 24/7 A donation to the orphans of firefighters: https://tinyurl.com/donorphelinsSP Assuming a duty of reliability 24/7, working staggered or atypical hours is not within everyone's reach... Sleep deprivation and balancing life often weigh heavily in the balance. Make a donation to the wards and orphans of firefighters: https://don.odp-pompiers.fr/odp-latribune For employers, this often poses a problem in terms of recruitment, attractiveness, turnover, work stoppages and organization. For professionals themselves, the impacts in terms of quality of life, health and safety are numerous: fatigue, high blood pressure, illnesses, accidents related to night … Type: | 63 | 6 | 57 | 19 |
 | Mnemo Therapeutics Empower the body, cure the disease Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer. The paucity of actionable cancer-specific targets creates significant challenges in the field of immuno-oncology. To address this, Mnemo has developed a combination of in-silico and wet-lab pipelines to uncover new tumour-specific targets (called E-antigens) derived from the unexploited dark genome, and to develop multiple therapeutic modalities (i.e. cell therapy, TCE, ADC, vaccine) targeting these E-antigens. Mnemo is currently pursuing several discovery campaigns for E-antigens, with a plan to develop its proprietary tumour-specific … Type: | 6 | 5 | 3 | 34 |
 | Resilience [Automatic translation follows] Better cancer care through digital technology Resilience is a company dedicated to remote monitoring and support for oncology patients whose mission is to better treat cancer. Through synergistic tools intended for patients and those who care for them, Resilience provides a global solution aimed at humanizing, streamlining and personalizing care pathways. The Resilience mobile application supports people affected by cancer on a daily basis to help them better cope with the side effects caused by their treatments and improve their quality of life. Resilience's remote monitoring platform, a class IIa medical device, allows healthcare professionals to better … Tags: FrenchTech2030 Type: | 46 | 43 | 29 | 181 |
 | Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a pioneering biotechnology company revolutionizing the treatment of patients with neurodegenerative or neurovascular diseases by targeting blood-brain barrier (BBB) dysfunctions and neuroinflammation. In the pathophysiology of various neurological diseases such as stroke, multiple sclerosis, and Parkinson's disease, the hyperactivation of endothelial NMDA receptors (NMDAr) by tissue plasminogen activator (tPA) overexpressed in these patients leads to the degradation of tight junctions and BBB dysfunction, allowing the transmigration of inflammatory cells and toxic molecules into the brain parenchyma, triggering excitotoxicity and neuroinflammation, major contributors to neurodegeneration. Lys Therapeutics' lead … Type: | 20 | 5 | 14 | 12 |
 | Woodoo Augmented wood / Decarbonized materials for a new industrial revolution. Woodoo is unlocking the future of construction—leading the way toward more sustainable, resilient cities. How? By transforming underutilized hardwood into a cutting-edge wood composite material: STACK. STACK redefines what wood can do, providing a low-carbon and high-performance alternative to steel, aluminum and concrete for cladding and structural building applications. Tags: FrenchTech2030 Type: | 67 | 25 | 53 | 48 |
 | DEXSTR Insight Engine for Life Sciences DEXSTR is an innovative software company founded by bioinformatics experts experienced working in major pharmaceutical groups. In the course of their careers, the team realized just how much time laboratories spent trying to manage their unstructured data, and so they decided to come up with a solution: an Insight Engine for Life Sciences. With Inquiro, DEXSTR uses Artificial Intelligence combined with scientific public ontologies, to transform unmanageable data into structured and actionable information. Inquiro captures your scientific data, from any source, in any format, automatically associating metadata to your files and offers an intelligent search … Type: | 3 | 0 | 2 | 3 |
 | Kezar Life Sciences Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be … Type: | 1 | 1 | 0 | 71 |
 | LifeScience WorldWide LifeScience & Biotech Worldwide Biotech Developments Type: | 14 | 0 | 14 | 1 |
 | National Center for Biotechnology Information (NCBI) Official account of the National Center for Biotechnology Information (NCBI) at the National Library of Medicine. NCBI serves as an international resource for the scientific research community - providing access to public databases and software tools for analyzing biological data, as well as performing research in computational biology. The NCBI was established in 1988 by an act of the United States Congress as division of the National Library of Medicine at the National Institutes of Health, with a mission to find new approaches to deal with the increasing volume and complexity of biological data in order to facilitate the understanding … Type: | 1 | 1 | 0 | 368 |
 | EMA Pharmaceuticals Leading sealing solutions for pharma- and diagnostic applications - Made in France. EMA Pharmaceuticals is a global actor in the development, manufacturing and marketing of sealing solutions for pharmaceutical containers. Specifically focused on closures for parenteral drug applications, EMA Pharmaceuticals currently serve more than 170 production sites of injectable medicine across the 5 continents. Our ambition is to enhance patients’ safety by providing Pharmaceutical Industry worldwide with clean-certified closure systems, manufactured according highest industry standards, ensuring optimal product integrity, drug recognition and ease of use by healthcare workers. Closure Systems for Pharmaceutical Containers, Primary Packaging Materials for Parenteral Drugs, and … Type: | 1 | 0 | 1 | 39 |
 | ten23 health Design. Formulate. Deliver. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development Type: | 4 | 2 | 2 | 164 |
 | UMR Right We are an immunology lab pursuing innovative ways to control cancer as well as inflammation in diseases and graft. UMR Right is a joint research unit affiliated to INSERM (National Institute of Health and Medical Research), EFS (French Blood Bank Institute) and the University of Franche-Comté. We develop basic, translational and clinical research programs to improve knowledge, diagnosis and treatments in the context of cancer immunity and immunotherapy (Team: TIMC), and organ and cell transplantation, inflammatory and autoimmune diseases (Team: ATI). Our main goals: - Characterize the pathogenic or protective immune responses involved in these diseases in order to identify … Type: | 7 | 3 | 1 | 36 |
 | UMMON HealthTech A “Software as a Medical Device” (SaMD) company developing proprietary AI-powered image analytics and predictive models. At UMMON HealthTech, we envision a world where algorithms improve patient care worldwide through earlier, more accurate and more affordable cancer diagnosis. By using AI and deep learning, we help Pathologists identify cancerous cells more accurately and earlier. Our platform provides end-to-end data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses. AI in Pathology UMMON HealthTech has patented a proprietary AI-powered platform for pathology analysis. We are currently focusing on bringing to the market a “Software as a Medical Device” for the … Type: | 4 | 3 | 1 | 13 |
 | Inside Therapeutics (InsideTx) Revolutionizing nanoparticle and RNA-LNP formulation with innovative microfluidic-based systems! At InsideTX, we are revolutionizing nanoparticle manufacturing, to unlock the full potential of RNA-LNP therapeutics and nanomedicines. At the convergence of microfluidics and biotechnology, we strive to provide laboratories, biotech, and pharma companies with the ultimate nanoparticle synthesis capabilities by solving three of the biggest challenges of the RNA-LNP revolution: Easing screeening, ensuring seamless scalability all along the development process and allowing for continuous production. Leveraging our patented technology, our complementary team is developping the only end-to-end nanoparticle synthesis platform that accelerates your screening to production time while improving your probability … Type: | 19 | 6 | 9 | 12 |
 | Maxion Therapeutics Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins. Type: | 1 | 0 | 1 | 34 |
 | International Association for the Study of Lung Cancer Conquering thoracic cancers worldwide. The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer. Founded in 1974, the association’s membership includes nearly 9,000 lung cancer specialists in over 100 countries. The IASLC's seeks to conquer thoracic cancers worldwide through educating scientists, medical professionals and the public on all aspects of lung cancer and other thoracic malignancies. The association publishes the Journal of Thoracic Oncology, a primary resource on the detection, prevention, diagnosis and treatment of lung cancer. Finally, each year the IASLC also hosts the IASLC World … Type: | 12 | 8 | 7 | 89 |
 | The Structural Genomics Consortium (SGC) A public-private partnership seeking to accelerate drug discovery through pre-competitive, open access research The SGC catalyses research in new areas of human biology and drug discovery by focusing explicitly on less well-studied areas of the human genome. The SGC accelerates research in these new areas by making all its research output available to the scientific community with no strings attached, and by creating an open collaborative network of scientists in hundreds of universities around the world and in eight global pharmaceutical companies. Together, this network of academic and industry scientists is driving a new scientific and drug discovery ecosystem whose … Type: | 17 | 4 | 17 | 68 |
 | SoundBio Lab Empowering communities through equitable access to life sciences. SoundBio Lab advances equity in life sciences by providing resources & education to the greater Seattle area. Through learning by doing we enable community-driven contributions to science, foster interdisciplinary exploration, and encourage career development. Type: | 0 | 0 | 0 | 7 |
 | Oncodesign Services A leading CRO in drug discovery and preclinical services Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing, Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.). Oncodesign Services offers a full spectrum of services in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology (including humanized models). This … Type: | 14 | 9 | 8 | 197 |
 | Stem Genomics Next generation quality control for cell therapy Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding … Type: | 2 | 1 | 1 | 10 |
 | SEQENS In Vitro Diagnostic SEQENS In Vitro Diagnostic | Blood fractionation for IVD | Located in Limoges (France), H2B manufactures fractionated blood products for the life sciences and IVD industries. Thanks to over 20 years of experience, the company has developed a considerable expertise in blood fractionation, extraction and purification. H2B offers a wide range of products including BSA and bovine fibrinogen on the one hand, human sera and plasma on the other. Visit our website for more informations and to find the complete listing of products (www.h2b.fr). in vitro diagnostic and blood fractionation | 0 | 0 | 0 | 10 |
 | Science Animation Midi-Pyrénées Science Animation Midi-Pyrénées is a company based out of France. | 0 | 0 | 0 | 7 |
Startup